Académique Documents
Professionnel Documents
Culture Documents
• Superficial
Involve skin&sc tissue
International 5-34 %
USA 14-16 %
KAUH ??
Surgical Operation Classification
• Clean <2 %
• Clean-contaminated <10 %
• Contaminated 20 %
• Dirty infected 40 %
CDC,1996:Cruse,1980
Wound Healing
*Inflamation
vascular
cellular
*Epithalisation
*Fibroplasia
*Wound contraction
Wound infection in gyne ward in
KAUH in 2002
• 13 cases ??
• Post cesarean section 8 cases ??
• Post myomectomy 2 cases
• Post lap for ectopic pregnancy 1 case
• Post lap for endometrial cancer 1case
• Post lap for ovarian cancer 1 case
Risk Factors
Altered immunocomptence
Old age
Obesity
Prolong preoperative hospitalization
Excessive blood loss
Prolong operative time
Poor nutrition
Excessive devitalize tissue
Failure to use prophylactic antibiotic
Surgery of an infected operative site
Diabetes mellitus
Pathogens commonly associated
with wound infection
PATHOGEN FREQUENCY %
Staphylococcus aureus 20
Coagulase-neg stphylococci 14
Enterococci 12
E-coli 8
Pseudomonas aeruginosa 8
Enterobacter species 7
Klebsiella pneumonia 3
Bacteriod fragilis 2
Prevention
1- Preoperative assessment
• Identify&treat all infections remote from
the surgical site
• Surgical site hair removal (level 1a)
• Stop smoking
• Optimize blood glucose (level 1b)
Prevention
• 2- Theater environment&care of
instrumentation
Appropriate filters
Air should enter through the ceiling&exit
near the floor Maintain positive
pressure ventilation of OR
Maintain mini of 15 air
changes/hr
( category 1B)
Prevention
3)Preoperative and postoperative wound care
*Handle tissues gently with good
homeostasis
*minimized dead space
* contaminated, dirty-infected wound use
delayed closure(secondary intention)
level 1b
Prevention
• What ?
• Double-blind, controlled
• Efficacy ,safety of single 1g dose of ceftizoxime
compare with three doses of 2 g cefoxitin
• Prophylactic success rates after vaginal
hysterectomy 91% for ceftizoxime and 85.1% for
cefoxitin
• After abdominal hysterectomy success rates
75.3% for both groups
J Am Coll surg 1994 feb
Single dose versus multiple –
dose prophylactic antibiotic
Randomized trial of one versus three doses of Augmentin as
wound prophylaxis
• Hydrogen peroxide
• honey
Choice of antibiotic
1-post operative wound infection without sepsis (no
GIT,FGT)
*Keflex 500mg po q6 h
*Augmentin 500 mg po q8 h
*Dicloxacillin 500 mg po q6 h
+/-
*Ciprofloxacin 500 mg po q12 h
Choice of antibiotic
• 2) Post. Op. wound infection with sepsis (surgery
involving GIT,FGT)
*Cefoxitin 1gm iv q6h or
*Timentin 3.1gm iv q6h
*Cefotaxime 1gm iv q 8 h,
*Ceftriaxone 1-2 gm iv q 24 h
+
*flagyl iv q8h or imipenum 500 mg iv q6 h